Erbe Vio
Payments companies reported to CMS as associated with Erbe Vio. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Erbe Vio, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Erbe Vio
These are the largest totals companies reported as associated with Erbe Vio. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Lonny Yarmus | Baltimore, MD | Pulmonary Disease | $10,991.15 |
| Binoy Ouseph | Montgomery, OH | Gastroenterology (Internal Medicine) | $200.00 |
| Artur Vargas Viana | Brooklyn, NY | Gastroenterology (Internal Medicine) | $100.00 |
| Sanmeet Singh | Frederick, MD | Gastroenterology (Internal Medicine) | $100.00 |
| Prashanth Rau | Worcester, MA | Gastroenterology (Internal Medicine) | $96.87 |
| Christopher Marshall | Worcester, MA | Gastroenterology (Internal Medicine) | $96.87 |
| Talal Seoud | Chillicothe, OH | Gastroenterology (Internal Medicine) | $90.00 |
| Praveen Nallapareddy | East Chicago, IN | Gastroenterology (Internal Medicine) | $17.00 |
| Jerry Jomi | Philadelphia, PA | Internal Medicine | $17.00 |
| Anil Nagar | New Haven, CT | Gastroenterology (Internal Medicine) | $17.00 |
Prescribed Erbe Vio?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.